← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Nov 15, 2025
Timeline
1980s
- Jan 1, 1987
Gruppo Oncologico del Nord-Ovest— Founded
Drugs by trial phase (33 distinct, 38 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Esophageal Neoplasms
- Head and Neck Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Rectal Neoplasms
- Squamous Cell Carcinoma of Head and Neck
Recent trials (39)
- NCT07094893Lead sponsorPhase 4Nov 15, 2025
- NCT06897644Lead sponsorPhase 3Mar 27, 2025
- NCT06869473Lead sponsorPhase 2Feb 20, 2025
- NCT06733038Lead sponsorPhase 3Nov 15, 2024
- NCT06578559Lead sponsorPhase 2Jul 23, 2024
- NCT06332079Lead sponsorPhase 2Mar 13, 2024
- NCT06037980Lead sponsorPhase 2/Phase 3Nov 7, 2023
- NCT05845450Lead sponsorPhase 2May 11, 2023
- NCT05594290Lead sponsorPhase 2Nov 30, 2022
- NCT05253846Lead sponsorPhase 2Jan 25, 2022
- NCT05062889Lead sponsorPhase 2Dec 31, 2021
- NCT04825990Lead sponsorPhase 2Jun 12, 2021
- NCT04817826Lead sponsorPhase 2Apr 1, 2021
- NCT04681469Lead sponsorPhase 2Feb 1, 2021
- NCT04806646Lead sponsorPhase 2Jan 12, 2021
Details
- Founded
- Genoa, IT Jan 1, 1987
- Last known activity
- Nov 15, 2025